Ryochi Ishibashi
Keio University
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Ryochi Ishibashi.
International Journal of Radiation Oncology Biology Physics | 2000
Atsuya Takeda; Naoyuki Shigematsu; Makoto Kondo; Atsushi Amemiya; Osamu Kawaguchi; Michinao Sato; Shoji Kutsuki; Kazuhito Toya; Ryochi Ishibashi; Takatsugu Kawase; Nobuhiro Tsukamoto; Atsushi Kubo
PURPOSE The two-portal tangential irradiation technique has usually been applied to breast cancer patients after breast-conserving surgery (1, 2) and is expected to irradiate the axillary lymph node region to some extent (3). We investigated the range of the axillary region covered by this technique and tried to devise an optimal irradiation technique (modified tangential irradiation) that would cover the axillary lymph node region properly. METHODS AND MATERIALS We checked the status of the surgical clips left at axillary lymph node sites by reviewing the simulator films and planning CT scans of 63 patients who underwent axillary dissection of level I, I-II, or I-III lymph nodes. Then we created the modified tangential irradiation technique and applied this technique to 16 patients and checked the irradiation volume by CT scans. RESULTS We found that all of the surgical clips on lateral-view simulator films were on the ventral side of the dorsal edge line of the humeral head. All but one clip were on the caudal side of the caudal edge line of the humeral head. Accordingly, it is possible to irradiate almost all axillary lymph node regions by setting the dorsal edge of the irradiation field on lateral-view simulator films at the dorsal edge of the humeral head and the cranial edge at the caudal edge of the humeral head. CONCLUSIONS All breast tissue and the entire axillary lymph node region can be covered by the modified tangential irradiation technique without increasing the lung volume irradiated.
Annals of Nuclear Medicine | 1996
Kayoko Nakamura; Toshikazu Sammiya; Jun Hashimoto; Ryochi Ishibashi; Kazuhiro Matsumoto; Atsushi Kubo
The uptake and washout kinetics of two cationic lipophilic99mTc-labeled myocardial perfusion agents,99mTc-methoxyisobutylisonitrile (99mTc-MIBI) and99mTc-l,2-bis[bis-(2-ethoxyethyl)-phosphino]ethane (99mTc-Tetrofosmin), were studied in cultured smooth muscle cells and compared to the conventional myocardial perfusion agent,201Tl. Both99mTc-MIBI and99mTc-Tetrofosmin had a 4-fold greater uptake than201Tl, and they were washed out of cells through similar kinetics which had slower rates than201T1. Incubation with metabolism inhibitors had a modest influence on the uptake of these two99mTc-labeled agents, although their extent and inhibited sites were slightly different. Ion transport inhibitors did not affect the uptake of99mTc-MIBI, although the99mTc-Tetrofosmin uptake was slightly inhibited when the Ca2+ channel was blocked. Our studies indicate that99mTc-MIBI and99mTc-Tetrofosmin were taken up by smooth muscle cells in similar pharmacokinetic patterns, but their accumulation reflected a different meaning for cell viability.
International Journal of Radiation Oncology Biology Physics | 2001
Atsuya Takeda; Naoyuki Shigematsu; Makoto Kondo; Atsushi Amemiya; Noriko Ihara; Osamu Kawaguchi; Ryochi Ishibashi; Etsuo Kunieda; Atsushi Kubo; Hisao Ito
150 patients, HER2/neu epxression was not associated with estrogen receptor (ER) or progesterone receptor (PR) status (p 0.98 and 0.62 respectively). HER2/neu status did not significantly impact either the incidence of local recurrence (LC)(p 0.13) or the type of first failure (p 1.0). Kaplan-Meier curves for overall survival (OS), cause-specific survival (CSS) and freedom from distant metastases (FFDM) did not show a significant difference in outcome between HER2/neu positive and negative patient groups (p 0.86, 0.42, and 0.63 respectively).
International Journal of Radiation Oncology Biology Physics | 2004
Atsuya Takeda; Naoyuki Shigematsu; Tadashi Ikeda; Osamu Kawaguchi; Shoji Kutsuki; Ryochi Ishibashi; Etsuo Kunieda; Toshiaki Takeda; Kazuhiko Takemasa; Hisao Ito; Takashi Uno; Hiromitsu Jinno; Atsushi Kubo
Anticancer Research | 2001
Naoyuki Shigematsu; Tetsuya Kawata; Noriko Ihara; Osamu Kawaguchi; Shoji Kutsuki; Ryochi Ishibashi; Atsushi Kubo; Hisao Ito
International Journal of Molecular Medicine | 2001
Naoyuki Shigematsu; Noriko Ihara; Tetsuya Kawata; Osamu Kawaguchi; Atsuya Takeda; Ryochi Ishibashi; Shoji Kutsuki; Atsushi Kubo; Tatsuaki Kanai; Yoshiya Furusawa; Koichi Isobe; Takashi Uno; Hisao Ito
International Journal of Radiation Oncology Biology Physics | 2007
Takatsugu Kawase; A. Takeda; E. Kunieda; Ryochi Ishibashi; Y. Kamikubo; Akitomo Sugawara; Toshio Ohashi; Junichi Fukada; Naoyuki Shigematsu; Atsushi Kubo
Oncology Reports | 2001
Atsuya Takeda; Naoyuki Shigematsu; Makoto Kondo; Atsushi Amemiya; Osamu Kawaguchi; Shoji Kutsuki; Ryochi Ishibashi; Tetsuya Kawata; Katsuhiro Masago; Junichi Fukada; Atsushi Kubo
The Journal of JASTRO | 2003
Tsutomu Saito; Ryochi Ishibashi; Toshiyuki Okumura; Katsuyuki Karasawa; Hiroshi Sekine; Takeo Takahashi; Iku Nishiguchi; Kazuo Hatano; Masahiko Furukawa; Shigeyuki Murayama
Archive | 1998
Tetsuya Kawada; Naoyuki Shigematsu; Hisao Ito; Shoji Yamashita; Atsuya Takeda; Kazuhito Toya; Ryochi Ishibashi; Atsushi Kubo; Tatsuaki Kanai; Yoshiya Furusawa; 川田 哲也; 茂末 直之; 伊東 久夫; 山下 昌次; 武田 篤也; 戸矢 和仁; 石橋 了知; 久保 敦司; 金井 達明; 古澤 佳也